|
1
|
Stroumpos C, Manolaraki M and Paspatis GA:
Remifentanil, a different opioid: Potential clinical applications
and safety aspects. Expert Opin Drug Saf. 9:355–364.
2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Su X, Zhu W, Tian Y, Tan L, Wu H and Wu L:
Regulatory effects of propofol on high-dose remifentanil-induced
hyperalgesia. Physiol Res. 69:157–164. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Song YK, Lee C, Seo DH, Park SN, Moon SY
and Park CH: Interaction between postoperative shivering and
hyperalgesia caused by high-dose remifentanil. Korean J
Anesthesiol. 66:44–51. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ma JF, Huang ZL, Li J, Hu SJ and Lian QQ:
Cohort study of remifentanil-induced hyperalgesia in postoperative
patients. Zhonghua Yi Xue Za Zhi. 91:977–979. 2011.PubMed/NCBI(In Chinese).
|
|
5
|
Hu J, Chen S, Zhu M, Wu Y, Wang P, Chen J
and Zhang Y: Preemptive nalbuphine attenuates remifentanil-induced
postoperative hyperalgesia after laparoscopic cholecystectomy: A
prospective randomized double-blind clinical trial. J Pain Res.
13:1915–1924. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wang RD, Sheng XR, Guan WX, Wang M, Peng
C, Yang YY, Huang HG and Ning-Li and Jia WD: Flurbiprofen axetil
for postoperative analgesia in upper abdominal surgery: A
randomized, parallel controlled, double-blind, multicenter clinical
study. Surg Today. 50:749–756. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lenz H, Raeder J, Draegni T, Heyerdahl F,
Schmelz M and Stubhaug A: Effects of COX inhibition on experimental
pain and hyperalgesia during and after remifentanil infusion in
humans. Pain. 152:1289–1297. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Horvath B, Kloesel B, Todd MM, Cole DJ and
Prielipp RC: The evolution, current value, and future of the
American society of anesthesiologists physical status
classification system. Anesthesiology. 135:904–919. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Subramaniam K, Ibarra A, Ruppert K,
Mallikarjun K and Orebaugh S: Intraoperative remifentanil infusion
and postoperative pain outcomes after cardiac surgery-results from
secondary analysis of a randomized, open-label clinical trial. J
Cardiothorac Vasc Anesth. 35:458–466. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Reed MD and Van Nostran W: Assessing pain
intensity with the visual analog scale: A plea for uniformity. J
Clin Pharmacol. 54:241–244. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Ramsay MA, Savege TM, Simpson BR and
Goodwin R: Controlled sedation with alphaxalone-alphadolone. Br Med
J. 2:656–659. 1974.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Allen SM and Madrio ME: Ramsay sedation
scale project: Small, easy changes for a big effect on patient
safety. Crit Care Nurse. 39:64–66. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Angst MS: Intraoperative use of
remifentanil for TIVA: Postoperative pain, acute tolerance, and
opioid-induced hyperalgesia. J Cardiothorac Vasc Anesth. 29 (Suppl
1):S16–S22. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Shu RC, Zhang LL, Wang CY, Li N, Wang HY,
Xie KL, Yu YH and Wang GL: Spinal peroxynitrite contributes to
remifentanil-induced postoperative hyperalgesia via enhancement of
divalent metal transporter 1 without iron-responsive
element-mediated iron accumulation in rats. Anesthesiology.
122:908–920. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Roeckel LA, Le Coz GM, Gavériaux-Ruff C
and Simonin F: Opioid-induced hyperalgesia: Cellular and molecular
mechanisms. Neuroscience. 338:160–182. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ing Lorenzini K, Wainstein L, Spechbach H,
Sarasin F, Ramlawi M, Desmeules J and Piguet V: Opioid-related
adverse drug reactions in patients visiting the emergency division
of a tertiary hospital. Pharmacol Res Perspect.
10(e01033)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yiu CH, Gnjidic D, Patanwala A, Fong I,
Begley D, Khor KE, Rimington J, Bugeja B and Penm J: Opioid-related
adverse drug events in surgical patients: Risk factors and
association with clinical outcomes. Expert Opin Drug Saf.
21:1211–1223. 2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gao Y, Zhan W, Jin Y, Chen X, Cai J, Zhou
X, Huang X, Zhao Q, Wang W and Sun J: KCC2 receptor upregulation
potentiates antinociceptive effect of GABAAR agonist on
remifentanil-induced hyperalgesia. Mol Pain.
18(17448069221082880)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Fujii T and Nishiwaki K: Ketamine reduces
the dose of remifentanil required during prolonged head and neck
surgery: A propensity-matched analysis. Nagoya J Med Sci. 84:1–6.
2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Julius D: TRP channels and pain. Annu Rev
Cell Dev Biol. 29:355–384. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Huang YH, Lee MS, Lin YT, Huang NC, Kao J,
Lai HC, Lin BF, Cheng KI and Wu ZF: Postoperative drip-infusion of
remifentanil reduces postoperative pain-A retrospective observative
study. Int J Environ Res Public Health. 18(9225)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Saxena S, Gonsette K, Terram W, Huybrechts
I, Nahrwold DA, Cappello M, Barvais L and Engelman E: Gradual
withdrawal of remifentanil delays initial post-operative analgesic
demand after thyroid surgery; double-blinded, randomized controlled
trial. BMC Anesthesiol. 19(60)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Shin SW, Cho AR, Lee HJ, Kim HJ, Byeon GJ,
Yoon JW, Kim KH and Kwon JY: Maintenance anaesthetics during
remifentanil-based anaesthesia might affect postoperative pain
control after breast cancer surgery. Br J Anaesth. 105:661–667.
2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Choi E, Lee H, Park HS, Lee GY, Kim YJ and
Baik HJ: Effect of intraoperative infusion of ketamine on
remifentanil-induced hyperalgesia. Korean J Anesthesiol.
68:476–480. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ithnin FB, Tan DJA, Xu XL, Tan CH, Sultana
R and Sng BL: Low-dose S+ ketamine in target-controlled intravenous
anaesthesia with remifentanil and propofol for open gynaecological
surgery: A randomised controlled trial. Indian J Anaesth.
63:126–133. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Leal PC, Salomão R, Brunialti MK and
Sakata RK: Evaluation of the effect of ketamine on
remifentanil-induced hyperalgesia: A double-blind, randomized
study. J Clin Anesth. 27:331–337. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wu Z, Yu J, Lin Q, Li H, Zhang T, Tan H,
Lin W and Cao L: Effects of an intraoperative intravenous bolus
dose of dexmedetomidine on remifentanil-induced postinfusion
hyperalgesia in patients undergoing thyroidectomy: A double-blind
randomized controlled trial. Anesth Analg. 132:320–328.
2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wehrfritz A, Bauer M, Noel N, Ramirez-Gil
JF, Ihmsen H, Prottengeier J, Schüttler J and Bessiere B:
Evaluation of antihyperalgesic and analgesic effects of 35% nitrous
oxide when combined with remifentanil: A randomised phase 1 trial
in volunteers. Eur J Anaesthesiol. 38:1230–1241. 2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yalcin N, Uzun ST, Reisli R, Borazan H and
Otelcioglu S: A comparison of ketamine and paracetamol for
preventing remifentanil induced hyperalgesia in patients undergoing
total abdominal hysterectomy. Int J Med Sci. 9:327–333.
2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gress K, Charipova K, Jung JW, Kaye AD,
Paladini A, Varrassi G, Viswanath O and Urits I: A comprehensive
review of partial opioid agonists for the treatment of chronic
pain. Best Pract Res Clin Anaesthesiol. 34:449–461. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
McGrail K, Chapple AG, Stone G, Sutton EF
and Chappell NR: Systematic review and meta-analysis of
perioperative administration of acetazolamide for management of
postoperative pain after laparoscopy. JSLS.
26(e2022.00032)2022.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yu EH, Tran DH, Lam SW and Irwin MG:
Remifentanil tolerance and hyperalgesia: Short-term gain, long-term
pain? Anaesthesia. 71:1347–1362. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Schmidt S, Bethge C, Förster MH and
Schäfer M: Enhanced postoperative sensitivity to painful pressure
stimulation after intraoperative high dose remifentanil in patients
without significant surgical site pain. Clin J Pain. 23:605–611.
2007.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Santonocito C, Noto A, Crimi C and
Sanfilippo F: Remifentanil-induced postoperative hyperalgesia:
Current perspectives on mechanisms and therapeutic strategies.
Local Reg Anesth. 11:15–23. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Small C and Laycock H: Acute postoperative
pain management. Br J Surg. 107:e70–e80. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Jiang B and Ye S: Pharmacotherapeutic pain
management in patients undergoing laparoscopic cholecystectomy: A
review. Adv Clin Exp Med. 31:1275–1288. 2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Tang H, Dong A and Yan L: Day surgery vs.
overnight stay laparoscopic cholecystectomy: A systematic review
and meta-analysis. Dig Liver Dis. 47:556–561. 2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Angst MS, Koppert W, Pahl I, Clark DJ and
Schmelz M: Short-term infusion of the mu-opioid agonist
remifentanil in humans causes hyperalgesia during withdrawal. Pain.
106:49–57. 2003.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhang L, Shu R, Zhao Q, Li Y, Wang C, Wang
H, Yu Y and Wang G: Preoperative but not postoperative flurbiprofen
axetil alleviates remifentanil-induced hyperalgesia after
laparoscopic gynecological surgery: A prospective, randomized,
double-blinded, trial. Clin J Pain. 33:435–442. 2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Shimoyama N, Shimoyama M, Davis AM,
Monaghan DT and Inturrisi CE: An antisense oligonucleotide to the
N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced
nociception, hyperalgesia, and morphine tolerance. J Pharmacol Exp
Ther. 312:834–840. 2005.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Yu P, Zhang J and Wang J: Nalbuphine for
spinal anesthesia: A systematic review and meta-analysis. Pain
Pract. 22:91–106. 2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Jannuzzi RG: Nalbuphine for treatment of
opioid-induced pruritus: A systematic review of literature. Clin J
Pain. 32:87–93. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Weinbroum AA: Postoperative hyperalgesia-A
clinically applicable narrative review. Pharmacol Res. 120:188–205.
2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Koo CH, Yoon S, Kim BR, Cho YJ, Kim TK,
Jeon Y and Seo JH: Intraoperative naloxone reduces
remifentanil-induced postoperative hyperalgesia but not pain: A
randomized controlled trial. Br J Anaesth. 119:1161–1168.
2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Song JW, Lee YW, Yoon KB, Park SJ and Shim
YH: Magnesium sulfate prevents remifentanil-induced postoperative
hyperalgesia in patients undergoing thyroidectomy. Anesth Analg.
113:390–397. 2011.PubMed/NCBI View Article : Google Scholar
|
|
46
|
de Boer HD, Detriche O and Forget P:
Opioid-related side effects: Postoperative ileus, urinary
retention, nausea and vomiting, and shivering. A review of the
literature. Best Pract Res Clin Anaesthesiol. 31:499–504.
2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Davis MP, Fernandez C, Regel S and
McPherson ML: Does nalbuphine have a niche in managing pain? J
Opioid Manag. 14:143–151. 2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Martinez L, Ekman E and Nakhla N:
Perioperative opioid-sparing strategies: Utility of conventional
NSAIDs in adults. Clin Ther. 41:2612–2628. 2019.PubMed/NCBI View Article : Google Scholar
|
